Galan Lithium targets Q4 for first sales

• Galan Lithium confirms initial sales remain on track for Q4 2026 at its Argentine lithium project.
• The nanofiltration plant maintains over 98% sulphate rejection as site operations weather severe winter conditions.
• The company aims to achieve a 4ktpa LCE throughput rate in H1 2027 while advancing expansion works to reach 5.2ktpa.

Galan Lithium (ASX:GLN) announced that its Hombre Muerto West Phase 1 lithium chloride operation in Argentina remains on track to deliver its first concentrate sales in Q4 2026.

The update follows successful processing performance during severe winter weather in the Andes, where operations sustained minimal disruption.

"The nanofiltration plant is performing in line with our expectations, and the additional pressure vessel capacity being installed by Authium will further strengthen the plant's resilience," said Galan Lithium Managing Director Juan Pablo Vargas de la Vega.

The nanofiltration system achieved over 98% sulphate rejection across three months of data, supporting a target concentrate of 6% lithium content.

Galan stated that an initial throughput of 4,000 tonnes per annum of lithium carbonate equivalent is expected in the first half of 2027.

Following the announcement, the Galan Lithium share price was unchanged at $0.38.

The company has initiated earthworks to expand Phase 1 capacity to 5,200 tonnes per annum, with higher output expected in the second half of 2027.